Not sure what to get for Christmas, check out the training courses we have next year ;0)
See the new website for online and other locations http://www.certarauniversity.com/lms/ Intro to Phoenix WinNonlin, 22-24 Feb 2017, Barcelona, Spain Intro to Phoenix WinNonlin, 25-27 Apr (Tue-Thur) 2017, Basel, Switzerland Intro to Phoenix NLME (Thur-Fri) 27-28 Apr 2017 Basel, Switzerland Intermediate PKPD with Phoenix (Tue-Fri) 16-19 May, Copenhagen, Denmark Intermediate Population Modeling Methodology using Phoenix NLME 16-17 May 2017, Paris, France Advanced Pharmacometrics PK/PD Modeling Course using Phoenix NLME 18-19 May 2017, Paris, France PAGE Workshop - Advanced NLME 5-6 June 2017, Budapest, Hungary Intermediate Population Modeling Methodology using Phoenix NLME 10-11 Jul 2017, Crete, Greece Intro to Phoenix WinNonlin, 19-21 Sep 2017, Amsterdam, Netherlands Intro to Phoenix WinNonlin, 7-9Nov 2017, London, UK Intro to Phoenix NLME (Tue-Wed) 9-10 Nov, London, UK And please, especially with PharmPK's retirment, remember to *follow* the forum to get tips and discuss Phoenix with other users; https://support.certara.com/forums/ particularly the new PML School that supports the free webinar series; https://support.certara.com/forums/forum/34-pml-school/ Best regards for the holiday season and 2017, Simon. Simon DAVIS Senior Scientific Consultant [cid:image003.png@01D1D6CC.304CFF80] Work Mobile : +44 7500 190 212 >> note the new number! Facsimile : +1 801 991 7145 Personal Mobile : +44 7980 832 666 simon.da...@certara.com<mailto:simon.da...@certara.com> ______________________________________________________________________ NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
